GRA
NOV icon

Goehring & Rozencwajg Associates’s NOV NOV Stock Holding History

Goehring & Rozencwajg Associates’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-189,652
Closed -$2.69M – 44
2024
Q4 		$2.69M Sell
189,652
-5,591
-3% -$87.3K 0.55% 40
2024
Q3 		$3.12M Buy
195,243
+13,058
+7% +$232K 0.64% 40
2024
Q2 		$3.46M Buy
182,185
+17,300
+10% +$324K 0.69% 42
2024
Q1 		$3.22M Buy
164,885
+11,400
+7% +$212K 0.7% 45
2023
Q4 		$3.11M Buy
153,485
+5,005
+3% +$98.3K 0.75% 42
2023
Q3 		$3.1M Buy
148,480
+4,730
+3% +$94K 0.76% 40
2023
Q2 		$2.31M Buy
143,750
+14,195
+11% +$231K 0.66% 41
2023
Q1 		$2.4M Buy
129,555
+6,636
+5% +$143K 0.82% 38
2022
Q4 		$2.57M Buy
+122,919
New +$2.58M 0.91% 37

Other funds holding NOV

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Goehring & Rozencwajg Associates's NOV Position: Q1 2025 in Review

Goehring & Rozencwajg Associates sold out of NOV (NOV) in Q1 2025, closing a stake of 189,652 shares — an estimated $2.69M sold.

Goehring & Rozencwajg Associates first reported a position in NOV in Q4 2022 and held it in 9 quarters. The position peaked at $3.46M in Q2 2024. 441 funds tracked by Wall St. Rank hold NOV as of Q1 2025.

  • Goehring & Rozencwajg Associates reported no remaining NOV position as of Q1 2025 after selling out during the quarter.
  • Goehring & Rozencwajg Associates sold 189,652 NOV shares in Q1 2025, an estimated $2.69M.
  • Goehring & Rozencwajg Associates first reported a position in NOV in Q4 2022 and held it in 9 quarters.
  • Goehring & Rozencwajg Associates's NOV position peaked at $3.46M in Q2 2024.
  • 441 funds tracked by Wall St. Rank held NOV as of Q1 2025.

Based on Goehring & Rozencwajg Associates's 13F filing for Q1 2025, filed 29 Apr 2025.